<DOC>
	<DOCNO>NCT01701505</DOCNO>
	<brief_summary>The purpose study assess efficacy safety intranasally administer Kovacaine Mist anesthetize maxillary teeth pediatric subject .</brief_summary>
	<brief_title>Dose-Ranging Study Intranasal Kovacaine Mist Pediatric Subjects</brief_title>
	<detailed_description>This single-center , open-label , randomize , parallel-groups , dose-ranging study ass efficacy safety intranasally administer Kovacaine Mist anesthetize maxillary teeth pediatric subject . The study employ open-label design determine lowest effective dos ( LEDs ) , assess safety efficacy Kovacaine Mist administer intranasally induce pulpal anesthesia maxillary primary teeth number A J maxillary permanent teeth number 4 13 ( maxillary right second premolar maxillary leave second premolar ) sufficient allow completion Study Dental Procedure , carry healthy child either sex age 3 17 year , inclusive .</detailed_description>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Male female 317 year age inclusive . Need operative restorative dental procedure single vital maxillary primary tooth ( # A J ) permanent tooth ( # 4 to13 ) , maxillary permanent first , second third molar , require local anesthesia expect treatment duration exceed 60 minute . Normal lip , nose , eyelid , cheek sensation . Accompanied and/or represent parent guardian able comprehend sign inform consent document . If age 8 , able understand provide inform assent . Patient parent/guardian able communicate investigator comply requirement protocol . Patency naris ipsilateral tooth undergo Study Dental Procedure . Minimum weight : Subjects Cohorts A B ( age 6 ) must weigh least 20kg ( 44 lb. ) . Subjects Cohort C ( age 3 ) must weigh least 10kg ( 22 lb. ) . Dental care require local anesthetic within 24 hour prior anticipate study participation . History allergy intolerance tetracaine , benzyl alcohol , ester local anesthetic , paraaminobenzoic acid ( find PABAcontaining sunscreen ) . History allergy hypersensitivity lidocaine , oxymetazoline , epinephrine , sulfite preservative . Use monoamine oxidase inhibitor within 3 week precede study entry . Nursing , pregnant , suspected pregnant , try become pregnant . ( Females childbearing potential require take urine pregnancy test day , prior , study drug administration rule pregnancy . ) Inadequately control thyroid disease type . Use investigational drug ( include Kovacaine Mist ) and/or participation clinical trial within 30 day study participation . Frequent nose bleeds ( ≥ 5 per month ) . Anticipated need use oxymetazoline phenylephrine nasal spray , nasal irrigation , nasal oral decongestant day study procedure . History congenital idiopathic methemoglobinemia . Clinically relevant history sinus/nasal surgery , recent epistaxis , nasal congestion sinus infection , use `` sinus medication '' within 48 hour prior anticipate study participation . History alcoholism and/or drug abuse . Pulpal pathology index tooth . Anticipated need use nitrous oxide Study Dental Procedure . Any chronic currently uncontrolled psychogenic , neurological , endocrine , pulmonary , cardiovascular , renal , gastrointestinal hepatic disease condition manifestation might confound interpretation study result make receipt study medication source risk adverse outcome . Fever define body temperature ≥100° ( 37°C ) day prior study drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>operative</keyword>
	<keyword>dental procedure</keyword>
</DOC>